Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells
Keywords: Radiosensitization; Targeted agent; PARP inhibitor; Optimal biological dose; Olaparib (Lynparzaâ¢);